These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7882313)

  • 1. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
    Sekido Y; Pass HI; Bader S; Mew DJ; Christman MF; Gazdar AF; Minna JD
    Cancer Res; 1995 Mar; 55(6):1227-31. PubMed ID: 7882313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma.
    Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL
    Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
    Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
    Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines.
    Sekido Y; Bader S; Latif F; Gnarra JR; Gazdar AF; Linehan WM; Zbar B; Lerman MI; Minna JD
    Oncogene; 1994 Jun; 9(6):1599-604. PubMed ID: 8183553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
    Schipper H; Papp T; Johnen G; Pemsel H; Bastrop R; Müller KM; Wiethege T; Jaworska M; Krismann M; Schiffmann D; Rahman Q
    Int J Oncol; 2003 May; 22(5):1009-17. PubMed ID: 12684666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
    Cheng JQ; Lee WC; Klein MA; Cheng GZ; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 1999 Mar; 24(3):238-42. PubMed ID: 10451704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
    Yoo NJ; Park SW; Lee SH
    Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines.
    Sekido Y; Bader SA; Carbone DP; Johnson BE; Minna JD
    Cancer Res; 1994 Sep; 54(18):4988-92. PubMed ID: 8069866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
    Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
    Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.
    Timmer T; Terpstra P; van den Berg A; Veldhuis PM; Ter Elst A; Voutsinas G; Hulsbeek MM; Draaijers TG; Looman MW; Kok K; Naylor SL; Buys CH
    Eur J Hum Genet; 1999; 7(4):478-86. PubMed ID: 10352938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
    Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
    Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
    Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
    Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
    Nagatake M; Takagi Y; Osada H; Uchida K; Mitsudomi T; Saji S; Shimokata K; Takahashi T; Takahashi T
    Cancer Res; 1996 Jun; 56(12):2718-20. PubMed ID: 8665501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
    Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations and deletions of the CBP gene in human lung cancer.
    Kishimoto M; Kohno T; Okudela K; Otsuka A; Sasaki H; Tanabe C; Sakiyama T; Hirama C; Kitabayashi I; Minna JD; Takenoshita S; Yokota J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):512-9. PubMed ID: 15701835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
    Bianchi AB; Mitsunaga SI; Cheng JQ; Klein WM; Jhanwar SC; Seizinger B; Kley N; Klein-Szanto AJ; Testa JR
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10854-8. PubMed ID: 7479897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.